-+ 0.00%
-+ 0.00%
-+ 0.00%

Australian Penny Stocks To Watch In September 2026

Simply Wall St·09/09/2026 05:23:50
Listen to the news

Global markets are reacting to higher government bond yields, which are reshaping how investors think about risk and return. When safer assets pay more, early stage shares need a clearer financial story to earn a spot in your portfolio. That is where financially solid Australian penny stocks come in. This article highlights three of the most financially disciplined low priced shares from our screener that investors are watching closely.

The three stocks below are just a starter set, and the full screen surfaced 394 more financially fit penny companies with equally compelling stories that are not covered here. To go beyond this short list, head into the Financially Fit Penny Stocks screener to identify, filter, and analyze the highest conviction ideas that match your own risk profile.

Alkane Resources (ASX:ALK)

Alkane Resources fits the Financially Fit Penny Stocks theme through its producing gold operations, anchored by the Tomingley mine in New South Wales, while also giving you exposure to a broader multi asset metals portfolio that goes beyond a single early stage project.

Alkane Resources runs gold exploration and production across several mines, with Tomingley, Bjorkdal and Costerfield together generating about A$936 million in revenue, and the business valued at roughly A$2.62b by the market.

"The main risk is that Alkane is now a more complex business. Instead of one operation, investors must understand three mines, three jurisdictions, different cost structures, underground mining risk, antimony market volatility, and a large future capex project at Boda-Kaiser."

What happens to Alkane Resources’ cash generation if one unseen pressure on its cost base or funding structure starts to bite harder than expected?

If that pressure point worries you, read the full narrative for Alkane Resources to see how Alkane Resources’ multi mine profile could turn complexity into optionality.

ASX:ALK Revenue & Expenses Breakdown as at Sep 2026
ASX:ALK Revenue & Expenses Breakdown as at Sep 2026

DroneShield (ASX:DRO)

DroneShield sits in the Financially Fit Penny Stocks theme through its DroneSentry counter drone platform, which targets high stakes defence and critical infrastructure customers that rely on repeat, contract based spending rather than one off gadget sales.

DroneShield develops and sells counter drone hardware and software such as the DroneSentry range, which is central to its A$270 million in Aerospace and Defense revenue. The business has a market value of about A$1.61b, putting it in mid cap territory for an early stage defence tech player.

"If management continues converting its growing pipeline into multi-year contracts while expanding margins through scale manufacturing, we could see a valuation re-rating over the next 12 to 24 months."

The real swing factor is how one emerging pattern in DroneShield’s customer relationships shapes demand resilience when budgets or priorities shift.

That swing factor is central to the full narrative for DroneShield, where you can see a potential decoupling among contract quality, pipeline momentum, and defence budgets.

ASX:DRO Earnings & Revenue Growth as at Sep 2026
ASX:DRO Earnings & Revenue Growth as at Sep 2026

Sigma Healthcare (ASX:SIG)

Sigma Healthcare gives this screener a very different flavour, with a full scale wholesale and pharmacy distribution engine that throws off real cash flow rather than relying on unproven concepts. This matters if you want penny stocks backed by everyday prescription spending.

Sigma Healthcare runs a pharmacy wholesale, distribution and franchising operation that generated about A$10.8b in Healthcare revenue, with the entire business valued at roughly A$30.8b by the market.

"Although Sigma Healthcare is benefiting from strong GLP-1 demand and an aging population that lifts prescription volumes, the GLP-1 category is dilutive to gross margin percentage."

What really shapes the Sigma Healthcare story now is how one pressure point in its profit mix eventually feeds through to earnings quality.

That pressure in the mix is exactly where the full narrative for Sigma Healthcare shows whether Sigma Healthcare’s margin squeeze is masking a sturdier earnings engine.

ASX:SIG Revenue & Expenses Breakdown as at Sep 2026
ASX:SIG Revenue & Expenses Breakdown as at Sep 2026

Seeking Alternatives Before The Crowd

Fresh opportunities move fast, and the stocks with real breakout potential rarely stay under the radar for long. Spot the momentum while it matters, then get in early.

  • Track dependable cash generators with strong balance sheets by scanning the curated list of solid balance sheet and fundamentals (11 results) before others spot their resilience and potential for a re-rating.
  • Review the curated 55 AI infrastructure stocks to follow AI-related momentum while these enablers of data and computing demand are still relatively under the radar.
  • Consider long-term electrification themes by using the focused 9 top copper producer stocks before copper supply constraints and infrastructure spending are fully reflected in market expectations.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.